NY A04732

Requires pharmacists to obtain express written consent from patients before substituting a prescribed drug with a less expensive generic drug product containing the same active ingredients, dosage form, and strength

Extends the written consent requirement to biological product substitutions, requiring patient approval before a pharmacist can substitute an interchangeable biological product for a less expensive alternative

Applies the consent requirement to out-of-state dispensers filling prescriptions for New York patients, replacing the previous rule that allowed other states' laws to prevail

Takes effect 90 days after becoming law, with immediate authorization for regulatory agencies to develop necessary rules for implementation